JACC: CardioOncology - Cancer-Associated Thrombosis: Trends in Clinical Features, Treatment and Outcomes From 2001 to 2020
Commentary by Dr. Yugo Yamashita

Commentary by Dr. Yugo Yamashita
Stephen Nicholls, MD, shares his experience starting a cardio-oncology service in Australia. Moderated by Alexandra Murphy, MD, PhD.
Commentary by Dr. Hari Narayan & Anna Narezkina
Commentary by Dr Hirotoshi Watanabe
Charlie Porter, MD, and Bonnie Ky, MD, MSCE, discuss the concept of permissive cardiotoxicity and applications for patient care in cardio-oncology.
Audio Summary of the December Issue with Introduction by Dr. Bonnie Ky
Commentary by Dr Alex Pui-Wai Lee
Commentary by Dr. Leilei Cheng
Zhicheng Hu, MD, and Edward Mei, MD, discuss atrial fibrillation burden and management in China.
Commentary by Dr. Candice Silversides and Dr. Valentin Fuster
Commentary by Dr. Emile Daoud
Commentary by Dr. Emile Daoud
Commentary by Dr. Sadeer Al-Kindi and Dr. Mohamad Alkhouli
Commentary by Dr. Douglas Mann and Dr. Elena Amin and Mr. Seth Wagner
Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides
James Januzzi, MD, and Bonnie Ky, MD, MSCE discuss the discovery of novel biomarkers of cancer therapy-related cardiotoxicity. Moderated by Nicholas Wilcox, MD, MHS.
Dimitrios Farmakis, MD, PhD, and Bonnie Ky, MD, MSCE, discuss SGLT-2 inhibitors and genetics, and applications for cardio-oncology practice.
Sumanta Pal, MD, discusses the treatment of patients with metastatic renal cell carcinoma (mRCC), management of cardiovascular toxicities associated with therapies for mRCC, and the future treatment landscape of mRCC. Moderated by Sarah Waliany, MD, MS.